SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022817
Filing Date
2020-05-07
Accepted
2020-05-07 16:02:30
Documents
68
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q torc-10q_20200331.htm 10-Q 1186724
2 EX-31.1 torc-ex311_7.htm EX-31.1 15639
3 EX-31.2 torc-ex312_9.htm EX-31.2 15740
4 EX-32.1 torc-ex321_10.htm EX-32.1 7787
  Complete submission text file 0001564590-20-022817.txt   5382296

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT torc-20200331.xml EX-101.INS 1272145
6 XBRL TAXONOMY EXTENSION SCHEMA torc-20200331.xsd EX-101.SCH 44781
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE torc-20200331_cal.xml EX-101.CAL 32917
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE torc-20200331_def.xml EX-101.DEF 150228
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE torc-20200331_lab.xml EX-101.LAB 340157
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE torc-20200331_pre.xml EX-101.PRE 274413
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 20856201
SIC: 2834 Pharmaceutical Preparations